Vivani Medical, Inc.
VANI

$71.28 M
Marketcap
$1.29
Share price
Country
$-0.01
Change (1 day)
$7.80
Year High
$0.84
Year Low
Categories

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

marketcap

Revenue of Vivani Medical, Inc. (VANI)

Revenue in 2023 (TTM): $

According to Vivani Medical, Inc.'s latest financial reports the company's current revenue (TTM) is $. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history of Vivani Medical, Inc.

Annual Revenue

Year Revenue Gross Profit Ebitda Income Before Tax Net Income
2023 $ $-357,000 $-26,608,000 $-25,652,000 $-25,652,000
2022 $ $-381,000 $-27,737,000 $-13,889,000 $-6,537,000
2021 $ $-345,000 $-13,619,000 $-12,773,000 $-12,132,000
2020 $ $-167,000 $-8,889,000 $-9,279,000 $-9,279,000
2019 $3.38 M $1.23 M $-30,183,000 $-33,592,000 $-33,592,000
2018 $6.9 M $2.01 M $-34,390,000 $-35,094,000 $-35,094,000
2017 $7.96 M $211 K $-28,252,000 $-28,516,000 $-28,516,000
2016 $3.99 M $-5,364,000 $-32,778,000 $-33,179,000 $-33,179,000
2015 $8.95 M $4.65 M $-19,712,000 $-20,018,000 $-20,018,000
2014 $3.4 M $-160,283 $-27,887,978 $-35,201,247 $-35,201,247
2013 $1.56 M $-4,064,387 $-17,639,537 $-22,968,925 $-22,968,925
2012 $1.37 M $-3,029,522 $-15,687,384 $-16,279,127 $-16,279,127